| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1851 | 2020 |
| Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study HS Hochster, LL Hart, RK Ramanathan, BH Childs, JD Hainsworth, ... Journal of Clinical Oncology 26 (21), 3523-3529, 2008 | 968 | 2008 |
| Fluoropyrimidine-associated cardiotoxicity: revisited MW Saif, MM Shah, AR Shah Expert opinion on drug safety 8 (2), 191-202, 2009 | 313 | 2009 |
| Pharmacokinetically guided dose adjustment of 5-fluorouracil: a rational approach to improving therapeutic outcomes MW Saif, A Choma, SJ Salamone, E Chu JNCI: Journal of the National Cancer Institute 101 (22), 1543-1552, 2009 | 279 | 2009 |
| Gastrointestinal perforation due to bevacizumab in colorectal cancer MW Saif, A Elfiky, RR Salem Annals of surgical oncology 14, 1860-1869, 2007 | 272 | 2007 |
| Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review N Makrilia, E Syrigou, I Kaklamanos, L Manolopoulos, MW Saif Metal‐Based Drugs 2010 (1), 207084, 2010 | 232 | 2010 |
| Neurotoxicity caused by the treatment with platinum analogues S Amptoulach, N Tsavaris Chemotherapy research and practice 2011 (1), 843019, 2011 | 229 | 2011 |
| Biology of colorectal cancer MW Saif, E Chu The Cancer Journal 16 (3), 196-201, 2010 | 225 | 2010 |
| Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia MW Saif, JL Hopkins, SD Gore Leukemia & lymphoma 43 (11), 2083-2092, 2002 | 209 | 2002 |
| Management of oxaliplatin-induced peripheral neuropathy MW Saif, J Reardon Therapeutics and clinical risk management 1 (4), 249-258, 2005 | 200 | 2005 |
| The role of mTOR in the management of solid tumors: an overview AS Strimpakos, EM Karapanagiotou, MW Saif, KN Syrigos Cancer treatment reviews 35 (2), 148-159, 2009 | 199 | 2009 |
| Gastric cancer in the elderly: an overview MW Saif, N Makrilia, A Zalonis, M Merikas, K Syrigos European Journal of Surgical Oncology (EJSO) 36 (8), 709-717, 2010 | 195 | 2010 |
| Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse … HJ Schmoll, C Twelves, W Sun, MJ O'Connell, T Cartwright, E McKenna, ... The Lancet Oncology 15 (13), 1481-1492, 2014 | 191 | 2014 |
| Increased prevalence of dihydropyrimidine dehydrogenase deficiency in African-Americans compared with Caucasians LK Mattison, J Fourie, RA Desmond, A Modak, MW Saif, RB Diasio Clinical cancer research 12 (18), 5491-5495, 2006 | 191 | 2006 |
| Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study PA Philip, J Lacy, F Portales, A Sobrero, R Pazo-Cid, JLM Mozo, EJ Kim, ... The lancet Gastroenterology & hepatology 5 (3), 285-294, 2020 | 189 | 2020 |
| AIDS and thrombosis: retrospective study of 131 HIV-infected patients MW Saif, R Bona, B Greenberg AIDS patient care and STDS 15 (6), 311-320, 2001 | 189 | 2001 |
| Panitumumab the first fully human monoclonal antibody: from the bench to the clinic M Cohenuram, MW Saif Anti-cancer drugs 18 (1), 7-15, 2007 | 172 | 2007 |
| HIV and thrombosis: a review MW Saif, B Greenberg AIDS patient care and STDs 15 (1), 15-24, 2001 | 171 | 2001 |
| Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy MD Goodman, S McPartland, D Detelich, MW Saif Journal of gastrointestinal oncology 7 (1), 45, 2016 | 170 | 2016 |
| Role and cost effectiveness of PET/CT in management of patients with cancer MW Saif, I Tzannou, N Makrilia, K Syrigos The Yale journal of biology and medicine 83 (2), 53, 2010 | 166 | 2010 |
